ASX

14.86

+0.88%↑

FROG

65.74

+3.04%↑

PII

69.68

+0.84%↑

NWL

3.77

-1.31%↓

DHC

5.06

+1.81%↑

ASX

14.86

+0.88%↑

FROG

65.74

+3.04%↑

PII

69.68

+0.84%↑

NWL

3.77

-1.31%↓

DHC

5.06

+1.81%↑

ASX

14.86

+0.88%↑

FROG

65.74

+3.04%↑

PII

69.68

+0.84%↑

NWL

3.77

-1.31%↓

DHC

5.06

+1.81%↑

ASX

14.86

+0.88%↑

FROG

65.74

+3.04%↑

PII

69.68

+0.84%↑

NWL

3.77

-1.31%↓

DHC

5.06

+1.81%↑

ASX

14.86

+0.88%↑

FROG

65.74

+3.04%↑

PII

69.68

+0.84%↑

NWL

3.77

-1.31%↓

DHC

5.06

+1.81%↑

Home・Aandelen Lijst・Nu Skin Enterprises Inc

Nu Skin Enterprises Inc

Gesloten

10.22 -1.92

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

10.19

Max

10.6

Belangrijke statistieken
By Trading Economics
Inkomsten	-4M 17M
Verkoop	-22M 364M
K/W Sectorgemiddelde	4.466 15.961
EPS	0.34
Dividendrendement	2.5
Winstmarge	4.689
Werknemers	3,100
EBITDA	-11M 32M

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	2.50% 7.01%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-53M 477M
Vorige openingsprijs	12.14
Vorige sluitingsprijs	10.22

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

5.78 / 6.16 Steun & Weerstand

Nu Skin Enterprises Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 dec 2025, 23:54 UTC

Populaire aandelen

Stocks to Watch: Nike, Cassava Sciences, KB Home

18 dec 2025, 23:51 UTC

Winsten

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18 dec 2025, 23:39 UTC

Belangrijke Marktbewegers

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18 dec 2025, 22:57 UTC

Acquisities, Fusies, Overnames

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18 dec 2025, 21:40 UTC

Winsten

Nike Sales Tick Up, But China Weakness Persists

18 dec 2025, 23:45 UTC

Marktinformatie

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18 dec 2025, 23:37 UTC

Marktinformatie

Winsten

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18 dec 2025, 23:36 UTC

Marktinformatie

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18 dec 2025, 23:03 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18 dec 2025, 23:02 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18 dec 2025, 23:00 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18 dec 2025, 22:59 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18 dec 2025, 22:58 UTC

Acquisities, Fusies, Overnames

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18 dec 2025, 22:57 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18 dec 2025, 22:56 UTC

Acquisities, Fusies, Overnames

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18 dec 2025, 22:55 UTC

Winsten

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dec 2025, 21:59 UTC

Winsten

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dec 2025, 21:50 UTC

Marktinformatie

Winsten

Tech, Media & Telecom Roundup: Market Talk

18 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

18 dec 2025, 21:35 UTC

Winsten

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18 dec 2025, 21:31 UTC

Winsten

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Greater China Rev Down 17% >NKE

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q EPS 53c >NKE

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Apparel Rev $3.91B >NKE

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Equipment Rev $550M >NKE

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q N Amer Rev $5.63B >NKE

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Footwear Rev $7.66B >NKE

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18 dec 2025, 21:15 UTC

Winsten

Nike 2Q Greater China Rev $1.42B >NKE

Peer Vergelijking

Prijswijziging

Nu Skin Enterprises Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Nu Skin Enterprises Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.78 / 6.16Steun & Weerstand

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.